UAlberta E. coli Drug Target: GlpG Protease vs Resistant Strains | AcademicJobs
UAlberta researchers identify GlpG protease as key to combating antibiotic-resistant E. coli in Nature Communications, promising new UTI treatments.
public-healthhigher-education-researchresearch-publication-news

